The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Telmisartan Market Research Report 2024
Synopsis
The global Telmisartan market was valued at US$ 3248.7 million in 2023 and is anticipated to reach US$ 3631.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Telmisartan include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan.
Report Scope
The Telmisartan market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Telmisartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Telmisartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Telmisartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Telmisartan market was valued at US$ 3248.7 million in 2023 and is anticipated to reach US$ 3631.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Telmisartan include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan.
Report Scope
The Telmisartan market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Telmisartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Telmisartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Telmisartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Telmisartan Market Overview
1.1 Product Overview and Scope of Telmisartan
1.2 Telmisartan Segment by Type
1.2.1 Global Telmisartan Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Segment by Application
1.3.1 Global Telmisartan Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Telmisartan Market Size Estimates and Forecasts
1.4.1 Global Telmisartan Revenue 2019-2030
1.4.2 Global Telmisartan Sales 2019-2030
1.4.3 Global Telmisartan Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Telmisartan Market Competition by Manufacturers
2.1 Global Telmisartan Sales Market Share by Manufacturers (2019-2024)
2.2 Global Telmisartan Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Telmisartan Average Price by Manufacturers (2019-2024)
2.4 Global Telmisartan Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Telmisartan, Product Type & Application
2.7 Telmisartan Market Competitive Situation and Trends
2.7.1 Telmisartan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Telmisartan Players Market Share by Revenue
2.7.3 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Telmisartan Retrospective Market Scenario by Region
3.1 Global Telmisartan Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Telmisartan Global Telmisartan Sales by Region: 2019-2030
3.2.1 Global Telmisartan Sales by Region: 2019-2024
3.2.2 Global Telmisartan Sales by Region: 2025-2030
3.3 Global Telmisartan Global Telmisartan Revenue by Region: 2019-2030
3.3.1 Global Telmisartan Revenue by Region: 2019-2024
3.3.2 Global Telmisartan Revenue by Region: 2025-2030
3.4 North America Telmisartan Market Facts & Figures by Country
3.4.1 North America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Telmisartan Sales by Country (2019-2030)
3.4.3 North America Telmisartan Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Telmisartan Market Facts & Figures by Country
3.5.1 Europe Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Telmisartan Sales by Country (2019-2030)
3.5.3 Europe Telmisartan Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Telmisartan Market Facts & Figures by Country
3.6.1 Asia Pacific Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Telmisartan Sales by Country (2019-2030)
3.6.3 Asia Pacific Telmisartan Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Telmisartan Market Facts & Figures by Country
3.7.1 Latin America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Telmisartan Sales by Country (2019-2030)
3.7.3 Latin America Telmisartan Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Telmisartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Telmisartan Sales by Country (2019-2030)
3.8.3 Middle East and Africa Telmisartan Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Telmisartan Sales by Type (2019-2030)
4.1.1 Global Telmisartan Sales by Type (2019-2024)
4.1.2 Global Telmisartan Sales by Type (2025-2030)
4.1.3 Global Telmisartan Sales Market Share by Type (2019-2030)
4.2 Global Telmisartan Revenue by Type (2019-2030)
4.2.1 Global Telmisartan Revenue by Type (2019-2024)
4.2.2 Global Telmisartan Revenue by Type (2025-2030)
4.2.3 Global Telmisartan Revenue Market Share by Type (2019-2030)
4.3 Global Telmisartan Price by Type (2019-2030)
5 Segment by Application
5.1 Global Telmisartan Sales by Application (2019-2030)
5.1.1 Global Telmisartan Sales by Application (2019-2024)
5.1.2 Global Telmisartan Sales by Application (2025-2030)
5.1.3 Global Telmisartan Sales Market Share by Application (2019-2030)
5.2 Global Telmisartan Revenue by Application (2019-2030)
5.2.1 Global Telmisartan Revenue by Application (2019-2024)
5.2.2 Global Telmisartan Revenue by Application (2025-2030)
5.2.3 Global Telmisartan Revenue Market Share by Application (2019-2030)
5.3 Global Telmisartan Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Telmisartan Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Telmisartan Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Telmisartan Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Telmisartan Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Telmisartan Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Reddy's Laboratories (UK)
6.6.1 Reddy's Laboratories (UK) Corporation Information
6.6.2 Reddy's Laboratories (UK) Description and Business Overview
6.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
6.6.5 Reddy's Laboratories (UK) Recent Developments/Updates
6.7 Hema Pharmaceuticals Pvt
6.6.1 Hema Pharmaceuticals Pvt Corporation Information
6.6.2 Hema Pharmaceuticals Pvt Description and Business Overview
6.6.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
6.7.5 Hema Pharmaceuticals Pvt Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Telmisartan Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Telmisartan Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Astellas Pharma Inc
6.10.1 Astellas Pharma Inc Corporation Information
6.10.2 Astellas Pharma Inc Description and Business Overview
6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Astellas Pharma Inc Telmisartan Product Portfolio
6.10.5 Astellas Pharma Inc Recent Developments/Updates
6.11 Nippon Boehringer Ingelheim
6.11.1 Nippon Boehringer Ingelheim Corporation Information
6.11.2 Nippon Boehringer Ingelheim Telmisartan Description and Business Overview
6.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
6.11.5 Nippon Boehringer Ingelheim Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Telmisartan Description and Business Overview
6.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Telmisartan Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Telmisartan Description and Business Overview
6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Takeda Telmisartan Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Beijing Wansheng Pharmaceutical
6.14.1 Beijing Wansheng Pharmaceutical Corporation Information
6.14.2 Beijing Wansheng Pharmaceutical Telmisartan Description and Business Overview
6.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
6.14.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Telmisartan Industry Chain Analysis
7.2 Telmisartan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Telmisartan Production Mode & Process
7.4 Telmisartan Sales and Marketing
7.4.1 Telmisartan Sales Channels
7.4.2 Telmisartan Distributors
7.5 Telmisartan Customers
8 Telmisartan Market Dynamics
8.1 Telmisartan Industry Trends
8.2 Telmisartan Market Drivers
8.3 Telmisartan Market Challenges
8.4 Telmisartan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
